Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Wellgistics Health (WGRX) EBITDA Margin (2024 - 2025)

Wellgistics Health filings provide 2 years of EBITDA Margin readings, the most recent being 2821.3% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 281359.0% to 2821.3% in Q4 2025 year-over-year; TTM through Dec 2025 was 91.11%, a N/A change, with the full-year FY2025 number at 91.11%, down 8317.0% from a year prior.
  • EBITDA Margin hit 2821.3% in Q4 2025 for Wellgistics Health, up from 1047.11% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 2821.3% in Q4 2025 to a low of 1286.52% in Q2 2024.